136 related articles for article (PubMed ID: 3096179)
1. Enhanced IgE-dependent basophil histamine release and airway reactivity in asthma.
Gaddy JN; Busse WW
Am Rev Respir Dis; 1986 Nov; 134(5):969-74. PubMed ID: 3096179
[TBL] [Abstract][Full Text] [Related]
2. Human basophil releasability. VI. Changes in basophil releasability in patients with allergic rhinitis or bronchial asthma.
Casolaro V; Spadaro G; Marone G
Am Rev Respir Dis; 1990 Nov; 142(5):1108-11. PubMed ID: 1700653
[TBL] [Abstract][Full Text] [Related]
3. Enhanced basophil histamine release to concanavalin A in allergic rhinitis.
Busse WW; Swenson CA; Sharpe G; Koschat M
J Allergy Clin Immunol; 1986 Jul; 78(1 Pt 1):90-7. PubMed ID: 2424961
[TBL] [Abstract][Full Text] [Related]
4. Human basophil releasability. III. Genetic control of human basophil releasability.
Marone G; Poto S; Celestino D; Bonini S
J Immunol; 1986 Dec; 137(11):3588-92. PubMed ID: 2431036
[TBL] [Abstract][Full Text] [Related]
5. Human basophil releasability. VIII. Increased basophil releasability in patients with scleroderma.
de Paulis A; Valentini G; Spadaro G; Lupoli S; Tirri G; Marone G
Arthritis Rheum; 1991 Oct; 34(10):1289-96. PubMed ID: 1718285
[TBL] [Abstract][Full Text] [Related]
6. Study of IgE-dependent basophil releasability in allergic patients.
Sanz ML; Latasa M; García BE; Gato JJ; Oehling A
J Investig Allergol Clin Immunol; 1991 Oct; 1(5):293-301. PubMed ID: 1727011
[TBL] [Abstract][Full Text] [Related]
7. Anti-human IgG causes basophil histamine release by acting on IgG-IgE complexes bound to IgE receptors.
Lichtenstein LM; Kagey-Sobotka A; White JM; Hamilton RG
J Immunol; 1992 Jun; 148(12):3929-36. PubMed ID: 1376345
[TBL] [Abstract][Full Text] [Related]
8. Leukotriene C4 formation by enriched human basophil preparations from normal and asthmatic subjects.
van der Donk EM; Blok W; Kok PT; Bruijnzeel PL
Prostaglandins Leukot Essent Fatty Acids; 1991 Sep; 44(1):11-7. PubMed ID: 1719566
[TBL] [Abstract][Full Text] [Related]
9. Human basophil releasability. I. Age-related changes in basophil releasability.
Marone G; Poto S; di Martino L; Condorelli M
J Allergy Clin Immunol; 1986 Feb; 77(2):377-83. PubMed ID: 2418093
[TBL] [Abstract][Full Text] [Related]
10. The influence of cimetidine and ranitidine on basophil histamine release and bronchial reactivity in asthmatic patients.
Hofman J; Michalska I; Kuczewska B; Chyrek-Borowska S
Agents Actions; 1987 Apr; 20(3-4):317-9. PubMed ID: 2440285
[TBL] [Abstract][Full Text] [Related]
11. Bimodal IgG4-mediated human basophil activation. Role of eosinophils.
Beauvais F; Hieblot C; Burtin C; Benveniste J
J Immunol; 1990 May; 144(10):3881-90. PubMed ID: 1692064
[TBL] [Abstract][Full Text] [Related]
12. Measurement of IgE on human basophils: relation to serum IgE and anti-IgE-induced histamine release.
Conroy MC; Adkinson NF; lichtenstein LM
J Immunol; 1977 Apr; 118(4):1317-21. PubMed ID: 66288
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of action of concanavalin A on human basophils.
Siraganian RP; Siragania PA
J Immunol; 1975 Feb; 114(2 pt 2):886-93. PubMed ID: 46257
[TBL] [Abstract][Full Text] [Related]
14. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils.
Columbo M; Horowitz EM; Botana LM; MacGlashan DW; Bochner BS; Gillis S; Zsebo KM; Galli SJ; Lichtenstein LM
J Immunol; 1992 Jul; 149(2):599-608. PubMed ID: 1378071
[TBL] [Abstract][Full Text] [Related]
15. Enhanced basophil releasability in subjects infected with human immunodeficiency virus.
Miadonna A; Leggieri E; Tedeschi A; Lazzarin A; Chianura L; Froldi M; Zanussi C
Clin Immunol Immunopathol; 1990 Feb; 54(2):237-46. PubMed ID: 1688523
[TBL] [Abstract][Full Text] [Related]
16. Human basophil releasability. II. Changes in basophil releasability in patients with atopic dermatitis.
Marone G; Giugliano R; Lembo G; Ayala F
J Invest Dermatol; 1986 Jul; 87(1):19-23. PubMed ID: 2425005
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of human basophil sulfidopeptide leukotriene release: releasability defined as the ability of the basophil to respond to dimeric cross-links.
MacGlashan DW; Peters SP; Warner J; Lichtenstein LM
J Immunol; 1986 Mar; 136(6):2231-9. PubMed ID: 2419427
[TBL] [Abstract][Full Text] [Related]
18. Does basophil releasability contribute to bronchial hyperreactivity in asthma?
Górski P
Allergol Immunopathol (Madr); 1987; 15(2):101-3. PubMed ID: 2441582
[TBL] [Abstract][Full Text] [Related]
19. Ionic regulation of human basophil releasability. I. Inhibitory effect of copper.
Tedeschi A; Arquati M; Lorini M; Milazzo N; Miadonna A
Agents Actions; 1992 Sep; 37(1-2):16-24. PubMed ID: 1280906
[TBL] [Abstract][Full Text] [Related]
20. The effect of interleukin 3 upon IgE-dependent and IgE-independent basophil degranulation and leukotriene generation.
Kurimoto Y; De Weck AL; Dahinden CA
Eur J Immunol; 1991 Feb; 21(2):361-8. PubMed ID: 1705512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
